Metis TechBio Co., Ltd. (HKG:7666)
Hong Kong · Delayed Price · Currency is HKD 12.73
-0.27 (-2.08%)
Jul 9, 2026, 4:08 PM HKT
Metis TechBio Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 |
| 105 | 1.48 | 9.34 | 0.55 | |
Revenue Growth (YoY) | 6985.02% | -84.13% | 1585.56% | - |
Cost of Revenue | 1.91 | 0.66 | 3.75 | 0.24 |
Gross Profit | 103.09 | 0.82 | 5.59 | 0.31 |
Selling, General & Admin | 223.64 | 111.42 | 111.74 | 136.36 |
Research & Development | 269.81 | 274 | 290.46 | 248.63 |
Other Operating Expenses | -15.9 | -13.41 | -3.95 | -7.89 |
Operating Expenses | 477.55 | 372.01 | 398.26 | 377.1 |
Operating Income | -374.47 | -371.19 | -392.67 | -376.79 |
Interest Expense | -31.81 | -168.5 | -70.2 | -1.91 |
Interest & Investment Income | 22.17 | 23.79 | 12.01 | 9.15 |
Currency Exchange Gain (Loss) | -11.25 | 12 | -7.85 | 4.92 |
Other Non Operating Income (Expenses) | -0.26 | -0.13 | -0.32 | -0.3 |
EBT Excluding Unusual Items | -395.61 | -504.03 | -459.04 | -364.93 |
Gain (Loss) on Sale of Investments | 4.63 | 6.85 | 0.1 | -1.6 |
Gain (Loss) on Sale of Assets | -0 | -0.61 | -0.5 | -0.46 |
Asset Writedown | -0.73 | -1.4 | -61.94 | - |
Other Unusual Items | - | - | -60.55 | -145.54 |
Pretax Income | -391.71 | -499.19 | -581.93 | -512.53 |
Income Tax Expense | 0.12 | 0.01 | 0 | - |
Net Income | -391.84 | -499.2 | -581.93 | -512.53 |
Net Income to Common | -391.84 | -499.2 | -581.93 | -512.53 |
Shares Outstanding (Basic) | 94 | 78 | 81 | 106 |
Shares Outstanding (Diluted) | 94 | 78 | 81 | 106 |
Shares Change (YoY) | 20.03% | -2.77% | -24.20% | - |
EPS (Basic) | -4.16 | -6.37 | -7.22 | -4.82 |
EPS (Diluted) | -4.16 | -6.37 | -7.22 | -4.82 |
Free Cash Flow | -140.25 | -242.55 | -241.92 | -195.72 |
Free Cash Flow Per Share | -1.49 | -3.09 | -3.00 | -1.84 |
Gross Margin | 98.18% | 55.53% | 59.81% | 56.14% |
Operating Margin | -356.63% | -25046.49% | -4205.10% | -68012.46% |
Profit Margin | -373.18% | -33684.08% | -6231.83% | -92515.16% |
Free Cash Flow Margin | -133.57% | -16366.46% | -2590.73% | -35328.52% |
EBITDA | -344.88 | -338.04 | -364.39 | -371.15 |
D&A For EBITDA | 29.59 | 33.15 | 28.28 | 5.64 |
EBIT | -374.47 | -371.19 | -392.67 | -376.79 |